patient risk stratification in cll and selection of treatment approaches
Published 2 years ago • 182 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
2:36
treatment approaches to cll with high-risk molecular features
-
2:13
risk stratification and personalized treatment in hl
-
3:24
improving risk stratification in all with risk scores & genomic studies to personalize therapy
-
5:03
understanding patient perspectives in cll treatment
-
1:11
patient selection in the treatment of cll
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
13:34
cll biology and patient stratification
-
7:24
what are the current cll treatment options?
-
3:30
significance of watch-and-wait approach in cll
-
3:16
identifying low- and high-risk aml
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
1:29
the importance of treatment sequencing in cll
-
1:18
involving the patient in treatment decisions for cll
-
1:36
selecting the best treatment option in cll
-
1:49
why is it important to risk stratify patients in cll?
-
3:02
limitations of current risk stratification systems in fl & treatment options for high-risk patients
-
2:25
monitoring infection risk in patients with cll & insights into the prevent-acall trial
-
0:56
the current treatment landscape in cll
-
7:58
cll risk stratification and treatment approach
-
2:00
associated toxicities of novel therapies for cll
-
1:15
risk stratification for ctcl
-
5:52
understanding ultra high-risk cll and advances with ibrutinib therapy